Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

AIM: To describe factors associated with treatment failure and frequency of resistance-associated substitutions (RAS). METHODS: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients starting a first direct-acting antiviral (DAA) regimen before February 2016 and included in t...

詳細記述

保存先:
書誌詳細
出版年:World J Hepatol
主要な著者: Salmon, Dominique, Trimoulet, Pascale, Gilbert, Camille, Solas, Caroline, Lafourcade, Eva, Chas, Julie, Piroth, Lionel, Lacombe, Karine, Katlama, Christine, Peytavin, Gilles, Aumaitre, Hugues, Alric, Laurent, Boué, François, Morlat, Philippe, Poizot-Martin, Isabelle, Billaud, Eric, Rosenthal, Eric, Naqvi, Alissa, Miailhes, Patrick, Bani-Sadr, Firouzé, Esterle, Laure, Carrieri, Patrizia, Dabis, François, Sogni, Philippe, Wittkop, Linda
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Inc 2018
主題:
Observational Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280155/
https://ncbi.nlm.nih.gov/pubmed/30533186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i11.856
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料